Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromes

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e3283377abcPMID 20145583PMCID PMC2842450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

  2009cited by this paper
• Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

  2009cited by this paper
• On the role of uncoupling protein-2 in pancreatic beta cells.

  2008cited by this paper
• The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men

  2008cited by this paper
• New-onset diabetes and antihypertensive drugs.

  2006cited by this paper
• An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model.

  2006cited by this paper
• Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.

  2006cited by this paper
• Variation in the UCP2-UCP3 Gene Cluster Predicts the Development of Type 2 Diabetes in Healthy Middle-Aged Men

  2006cited by this paper
• Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003.

  2006cited by this paper
• β2-Adrenergic Receptor Genotype and Survival AmongPatients Receiving β-Blocker Therapy After an Acute Coronary Syndrome

  2005cited by this paper
• Associations of the UCP2 Gene Locus With Asymptomatic Carotid Atherosclerosis in Middle-Aged Women

  2005cited by this paper
• Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

  2005cited by this paper
• The burden of diabetes-associated cardiovascular hospitalizations in Veterans Administration (VA) and non-VA medical facilities.

  2004cited by this paper
• Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.

  2004cited by this paper
• Uncoupling Protein 2 Promoter Polymorphism −866G/A Affects Its Expression in β-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients

  2004cited by this paper
• Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression*

  2004cited by this paper
• Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.

  2004cited by this paper
• Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.

  2004cited by this paper
• Common Genomic Response in Different Mouse Models of &bgr;-Adrenergic–Induced Cardiomyopathy

  2003cited by this paper
• A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.

  2002cited by this paper
• Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes.

  2001cited by this paper
• A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans

  2001cited by this paper
• Uncoupling protein 2: Adiposity angel and diabetes devil?

  2001cited by this paper
• Up‐regulation of uncoupling proteins by β‐adrenergic stimulation in L6 myotubes

  2001cited by this paper
• Characterization of a CREB Gain-of-Function Mutant with Constitutive Transcriptional Activity In Vivo

  2000cited by this paper
• Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

  1999cited by this paper
• Unstable angina. A classification.

  1989cited by this paper
• Unstable Angina A Classification

  1989cited by this paper

• The Association of UCP2-866 G/A Genotype with Autoimmune Hypothyroidism in the Southwestern Saudi Arabia Population

  2023cites this paper
• Downregulation of Uncoupling Protein 2(UCP2) Mediated by MicroRNA-762 Confers Cardioprotection and Participates in the Regulation of Dynamic Mitochondrial Homeostasis of Dynamin Related Protein1 (DRP1) After Myocardial Infarction in Mice

  2022cites this paper
• Association of uncoupling protein-2 -866G/A and Ala55Val polymorphisms with susceptibility to type 2 diabetes mellitus

  2021cites this paper
• Ethnicity Differences in the Association of UCP1-3826A/G, UCP2-866G/A and Ala55Val, and UCP3-55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta-Analysis

  2021cites this paper
• The interaction between energy intake, physical activity and UCP2 -866G/A gene variation on weight gain and changes in adiposity: an Indonesian Nutrigenetic Cohort (INDOGENIC)

  2020cites this paper
• The differential response to intermittent fasting diet versus low calorie diet with exercise based on -866 G/A UCP2 gene variation in adults with overweight/obesity

  2019cites this paper
• EPIDEMIOLOGICAL, TOXICOLOGICAL AND MOLEСULAR-GENETIC ASPECTS OF ENDOCRINE DISRUPTING CHEMICALS IN THE CHEMICAL SAFETY PROBLEM

  2018cites this paper
• Uncoupling Protein 2 in Cardiovascular Health and Disease

  2018cites this paper
• Perspectives and Potential Applications of Mitochondria‐Targeted Antioxidants in Cardiometabolic Diseases and Type 2 Diabetes

  2014cites this paper
• Estudo da associação de polimorfismos nos genes das UCPS com suscetibilidade ao diabetes mellitus tipo 2 e doença renal do diabetes

  2014cites this paper
• Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus: Case-Control Study and Meta-Analysis

  2013cites this paper
• Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease

  2013cites this paper
• The frequent UCP2 −866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes

  2013cites this paper
• Other Adjunctive Drugs for Coronary Intervention

  2012cites this paper
• The frequent UCP 2-866 G > A polymorphism protects against insulin resistance and is associated with obesity A study of obesity and related metabolic traits among 17

  2012cites this paper
• Personalized medicine triumvirate

  2012cites this paper
• Gene Polymorphism and Coronary Heart Disease

  2012cites this paper
• UCP2 −866G/A and Ala55Val, and UCP3 −55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study

  2011cites this paper